OVERVIEW

This conference will review the latest medications and therapies in liver treatment and transplantation. The results of trials and real-world data using oral drugs to treat chronic viral hepatitis B and C, non-alcoholic fatty liver diseases, primary biliary cirrhosis, primary sclerosing cholangitis, hepatocellular carcinoma and complications of end-stage liver disease including thrombocytopenia will be reviewed in detail. New Treatments in Chronic Liver Disease is a comprehensive yet concise program for updating physicians on these and other commonly encountered problems in the treatment of liver diseases. 

TARGET AUDIENCE

•  Hepatologists
• Gastroenterologists
• Infectious Disease Specialists

LEARNING OBJECTIVES

After attending this live activity, participants should be able to:

• Understand new nomenclature for steatotic liver disease.
• Assess new therapies for treating Metabolic Dysfunction-Associated Liver Disease.
• Review guidelines for the management of viral hepatitis including HBV, HCV and Delta.
• Understand advances in management of cholestatic liver disease, alcohol use disorder and liver masses.
• Address causes and trends of liver disease and liver transplantation in women.
• Evaluate Treatments for Advanced HCC.
• Outline recent advances in the understanding and management of portal hypertension, ascites and hepatorenal syndrome.

ACCREDITATION

Physicians

Scripps Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

For more information please visit the official event page.